Xentria Ramps Up Clinical Focus On Biosimilars In 2025
The Company Could Launch A Total Of Six Studies This Year
Adding to five new clinical trials launched in 2024, Xentria is doubling down on its ambitions in the biosimilars arena with up to six further studies in the coming year.
